In vivo neuroprotection in ischemic stroke by activated protein C requires β-arrestin 2
Open Access
- 15 November 2024
- journal article
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (1)
Abstract
No abstract availableKeywords
Funding Information
- University of Southern California (R01NS117827)
- National Institute of Neurological Disorders and Stroke (R01NS117827)
- National Heart, Lung, and Blood Institute (R01HL142975)
- National Institutes of Health
- The Scripps Research Institute (R01HL142975)
This publication has 22 references indexed in Scilit:
- A toolkit for stroke infarct volume estimation in rodentsNeuroImage, 2024
- Unraveling coagulation factor–mediated cellular signalingJournal of Thrombosis and Haemostasis, 2023
- β-Arrestins as Important Regulators of Glucose and Energy HomeostasisAnnual Review of Physiology, 2022
- aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete, β-arrestin-2–mediated SphK1-S1PR1-Akt signaling axisProceedings of the National Academy of Sciences, 2021
- The role and mechanism of β-arrestin2 in signal transductionLife Sciences, 2021
- Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic strokeScience Advances, 2021
- Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier functionProceedings of the National Academy of Sciences, 2020
- β-arrestin-2 in PAR-1-biased signaling has a crucial role in endothelial function via PDGF-β in strokeCell Death & Disease, 2019
- Mechanisms of signalling and biased agonism in G protein-coupled receptorsNature Reviews Molecular Cell Biology, 2018
- Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffoldsProceedings of the National Academy of Sciences, 2011